Antisense Oligonucleotide (AS-ODN) Technology: Principle, Mechanism and Challenges

Area of Science:

• Biotechnology
• Molecular Biology
• Pharmacology

Background:

• Antisense oligonucleotides (As-ODNs) are synthetic, single-stranded molecules designed to target specific mRNA sequences.
• These molecules function via sequence-specific hybridization, leading to mRNA cleavage or functional inhibition, thereby blocking gene expression.

Purpose of the Study:

• To review the mechanism of action of antisense oligonucleotides (As-ODNs).
• To discuss various chemical modifications of As-ODNs and their therapeutic applications.
• To highlight key challenges and future research directions for As-ODN therapeutics.

Main Methods:

• Review of existing literature on antisense oligonucleotide technology.
• Analysis of the molecular mechanisms underlying As-ODN action.
• Examination of different chemical modifications and their impact on efficacy and delivery.

Main Results:

• As-ODNs demonstrate potential in targeting gene expression for various diseases, including cancer and viral infections.
• The specificity of As-ODNs is enhanced by their unique sequence complementarity to target mRNA.
• Promising in vitro and in vivo findings exist, but clinical outcomes remain uncertain.

Conclusions:

• Antisense oligonucleotide therapy holds significant promise for treating genetic disorders, cancer, and infections.
• Optimization of efficacy, reduction of off-target effects, and improved delivery systems are crucial for clinical success.
• Continued investigation into As-ODN modifications and therapeutic strategies is essential.